Patents by Inventor Simon T. Barry

Simon T. Barry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190389967
    Abstract: The disclosure relates in some aspects to methods of treating and diagnosing ?V?6 overexpressing cancer. In some embodiments, the disclosure relates to methods of treating and diagnosing ?V?6 and HER2 overexpressing cancer. In some embodiments, combination therapy strategies are employed.
    Type: Application
    Filed: November 6, 2018
    Publication date: December 26, 2019
    Inventors: Simon T. Barry, John F. Marshall, Kate M. Moore
  • Publication number: 20170320954
    Abstract: The disclosure features a CXCR2 antagonist in combination with a checkpoint inhibitor (e.g., an anti-CTLA-4 antibody or an anti-PD-L1 antibody) and methods of using the combination to enhance anti-tumor activity in a subject.
    Type: Application
    Filed: November 16, 2015
    Publication date: November 9, 2017
    Inventors: SIMON T. BARRY, Simon HOLLINGSWORTH
  • Publication number: 20160319032
    Abstract: The disclosure relates in some aspects to methods of treating and diagnosing ?V?6 overexpressing cancer. In some embodiments, the disclosure relates to methods of treating and diagnosing ?V?6 and HER2 overexpressing cancer. In some embodiments, combination therapy strategies are employed.
    Type: Application
    Filed: October 1, 2014
    Publication date: November 3, 2016
    Applicant: Medlmmune Limited
    Inventors: Simon T. Barry, John F. Marshall, Kate M. Moore